These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1387741

  • 21. Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145.
    Kishino J, Hanasaki K, Nagasaki T, Arita H.
    Br J Pharmacol; 1991 Aug; 103(4):1883-8. PubMed ID: 1833018
    [Abstract] [Full Text] [Related]

  • 22. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ, Doran J, Jackson E, FitzGerald GA.
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [Abstract] [Full Text] [Related]

  • 23. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
    Reynolds EE, Mok LL.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):915-21. PubMed ID: 2138670
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
    Hunt JA, Merritt JE, MacDermot J, Keen M.
    Biochem Pharmacol; 1992 Apr 15; 43(8):1747-52. PubMed ID: 1315543
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV.
    J Pharmacol Exp Ther; 1992 Aug 15; 262(2):632-7. PubMed ID: 1386885
    [Abstract] [Full Text] [Related]

  • 27. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA, Naka M, Masuda A, Oatis JE, Okwu AK, Mais DE, Saussy DL, Halushka PV.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Aug 15; 21A():331-7. PubMed ID: 1825565
    [No Abstract] [Full Text] [Related]

  • 28. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA, Heran CL, Ogletree ML.
    Eicosanoids; 1990 Aug 15; 3(2):87-93. PubMed ID: 2144979
    [Abstract] [Full Text] [Related]

  • 29. Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.
    Bowling N, Dubé GP, Kurtz WL, Brune KA, Saussy DL, Dorn GW, Mais DE.
    J Mol Cell Cardiol; 1994 Jul 15; 26(7):915-23. PubMed ID: 7966360
    [Abstract] [Full Text] [Related]

  • 30. Thromboxane A2 receptor characterization in human astrocytoma cells and rabbit platelets by a new thromboxane antagonist, [3H]ONO NT-126.
    Takano S, Ishimoto H, Nakahata N, Nakanishi H.
    Res Commun Chem Pathol Pharmacol; 1992 May 15; 76(2):155-70. PubMed ID: 1534919
    [Abstract] [Full Text] [Related]

  • 31. Receptor binding properties of the new and specific thromboxane receptor antagonist Bay U 3405.
    Darius H, Michael-Hepp J, Meyer J.
    Agents Actions Suppl; 1992 May 15; 37():157-61. PubMed ID: 1385923
    [Abstract] [Full Text] [Related]

  • 32. Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor protein.
    Kim SO, Lim CT, Lam SC, Hall SE, Komiotis D, Venton DL, Le Breton GC.
    Biochem Pharmacol; 1992 Jan 22; 43(2):313-22. PubMed ID: 1739420
    [Abstract] [Full Text] [Related]

  • 33. Radioligand binding assays for thromboxane A2/prostaglandin H2 receptors.
    Halushka PV, Morinelli TA, Mais DE.
    Methods Enzymol; 1990 Jan 22; 187():397-405. PubMed ID: 2146462
    [No Abstract] [Full Text] [Related]

  • 34. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW.
    J Clin Invest; 1989 Dec 22; 84(6):1883-91. PubMed ID: 2531760
    [Abstract] [Full Text] [Related]

  • 35. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK, Rosolowsky M, Anderson HV, Golino P, NcNatt JM, De Clerck F, Buja LM, Willerson JT.
    J Am Coll Cardiol; 1990 Sep 22; 16(3):705-13. PubMed ID: 2143767
    [Abstract] [Full Text] [Related]

  • 36. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
    Mais DE, Saussy DL, Magee DE, Williams CM.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Sep 22; 21A():347-50. PubMed ID: 1825567
    [No Abstract] [Full Text] [Related]

  • 37. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
    Ito BR, Roth DM, Engler RL.
    Circ Res; 1990 Mar 22; 66(3):596-607. PubMed ID: 2137727
    [Abstract] [Full Text] [Related]

  • 38. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K, Mathur RS, Duzic E, Halushka PV.
    Am J Physiol; 1993 Dec 22; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.